Meeting between MiMedx and FDA postponed

|About: MiMedx Group Inc. (MDXG)|By:, SA News Editor

MiMedx Group (MDXG) says its meeting with the FDA (scheduled for today) regarding the letter the company received early last month has been postponed due to the government shutdown.

"As part of the partial Federal government shutdown, some of the key participants in the meeting remain on furlough," CEO Parker Petit says.

The regulator did not say when the rescheduled meeting would be held.

For more on the HCT/P issue, see here.